Pfizer Inc. ( PFE) - Key Metrics
PFE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $2.64 | -$0.04 | $0.15 | $0.05 |
| 2026Q1 | $2.54 | $0.47 | $0.46 | $0.38 |
| 2025Q4 | $3.09 | -$0.29 | $0.94 | $0.79 |
| 2025Q3 | $2.93 | $0.62 | $0.81 | $0.70 |
| 2025Q2 | $2.58 | $0.51 | -$0.10 | -$0.21 |
PFE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | -996.34% | -141.03 |
| 2026Q1 | 90.96% | 14.77 |
| 2025Q4 | -148.36% | -21.47 |
| 2025Q3 | 69.02% | 9.62 |
| 2025Q2 | 84.02% | 11.88 |
PFE Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.22% | 1.76% |
| 2026Q1 | 1.38% | 1.55% |
| 2025Q4 | 3.18% | 1.73% |
| 2025Q3 | 2.95% | 1.80% |
| 2025Q2 | -0.87% | 1.77% |
PFE
List: Challengers
Price: $26.86
Dividend Yield: 6.56%
Forward Dividend Yield: 6.42%
Payout Ratio: -365.22%
Dividend Per Share: 1.72 USD
Earnings Per Share: 0.76 USD
P/E Ratio: 35.21
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 23.8 million
Ebitda: 3.6 billionMarket Capitalization: 152.5 billion
Average Dividend Frequency: 4
Years Paying Dividends: 55
DGR3: 2.45%
DGR5: -1.34%
DGR10: 8.70%
DGR20: 6.30%